CD82 and breast carcinoma: Liprin-α1 suppresses the expression of the transmembrane metastasis suppressor CD82 in HNSCC and breast cancer cell lines [52], and the expression of liprin-α1 and CD82 is negatively correlated in clinical breast cancer samples [122].